The effect of the neutrophil elastase inhibitor sivelestat on early injury after liver resection

World Journal of Surgery

Volumn 36, Issue 5, 2012, Pages 1122-1127

  Tsujii, Shigehiro ^a   Okabayashi, Takehiro ^a   Shiga, Mai ^a   Takezaki, Yuka ^a   Sugimoto, Takeki ^a   Kobayashi, Michiya ^a   Hanazaki, Kazuhiro ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DRUG DERIVATIVE; GLYCINE; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 6; LEUKOCYTE ELASTASE; SERINE PROTEINASE INHIBITOR; SIVELESTAT; SULFONAMIDE;

AGED; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION; DRUG ANTAGONISM; FEMALE; HUMAN; LIVER; LIVER RESECTION; LIVER TUMOR; MALE; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY; TREATMENT OUTCOME;

AGED; BIOLOGICAL MARKERS; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLYCINE; HEPATECTOMY; HMGB1 PROTEIN; HUMANS; INTERLEUKIN-6; LEUKOCYTE ELASTASE; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REPERFUSION INJURY; SERINE PROTEINASE INHIBITORS; SULFONAMIDES; TREATMENT OUTCOME;

EID: 84863724955     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-012-1501-8     Document Type: Review

References (31)

1. Okabayashi T, Hnazaki K, Nishimori I et al (2008) Continuous post-operative blood glucose monitoring and control using a closed-loop system in patients undergoing hepatic resection. Dig Dis Sci 53:1405-1410
2. Okabayashi T, Yamamoto J, Kosuge T et al (2001) A new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables. Cancer 92:2374-2783
3. Laurent A, Cherqui D, Lesurtel M et al (2003) Laparoscopic liver resection for subcapsular hepatocellular carcinoma complicating chronic liver disease. Arch Surg 138:763-769
4. Yamashita Y, Hamatsu T, Rikimaru T et al (2001) Bile leakage after hepatic resection. Ann Surg 233:45-50
5. Tanaka S, Hirohashi K, Tanaka H et al (2002) Incidence and management of bile leakage after hepatic resection for malignant hepatic tumors. J Am Coll Surg 195:484-489
6. Ikeda Y, Kanematsu T, Matsumata T et al (1993) Liver resection and intractable postoperative ascites. Hepatogastroenterology 40:14-16
7. Figueras J, Llado L, Ruiz D et al (2005) Complete versus selective portal triad clamping for minor liver resections: a prospective randomized trial. Ann Surg 241:582-590
8. Ishizaki Y, Yoshimoto J, Miwa K et al (2006) Safety of prolonged intermittent Pringle maneuver during hepatic resection. Arch Surg 141:649-653
9. Maeda H, Okabayashi T, Nishimori I et al (2010) Hyperglycemia during hepatic resection: continuous monitoring of blood glucose concentration. Am J Surg 199:8-13
10. Bustin M (1999) Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol Cell Biol 19:5237-5246
11. Wang H, Yang H, Czura CJ et al (2001) HMGB1 as a late mediator of lethal systemic inflammation. Am J Respir Crit Care Med 164:1768-1773
12. Tsung A, Sahai R, Tanaka H et al (2005) The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med 201:1135-1143
13. Wang H, Vishnubhakat JM, Bloom O et al (1999) Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes. Surgery 126:389-392
14. Iba T, Kidokoro A, Fukunaga M et al (2006) Pretreatment of sivelestat sodium hydrate improves the lung microcirculation and alveolar damage in lipopolysaccharide-induced acute lung inflammation in hamsters. Shock 26:95-98
15. Yamazaki T, Ooshima H, Usui A et al (1999) Protective effects of ONO-5046Na, a specific neutrophil elastase inhibitor, on postperfusion lung injury. Ann Thorac Surg 68:2141-2146
16. Ishikawa N, Oda M, Kawaguchi M et al (2003) The effects of a specific neutrophil elastase inhibitor (ONO-5046) in pulmonary ischemia-reperfusion injury. Transpl Int 16:341-346
17. Kotake Y, Yamamoto M, Matsumoto M et al (2005) Sivelestat, a neutrophil elastase inhibitor, attenuates neutrophil priming after hepatoenteric ischemia in rabbits. Shock 23:156-160
18. Matsuzaki K, Hiramatsu Y, Homma S et al (2005) Sivelestat reduces inflammatory mediators and preserves neutrophil deformability during simulated extracorporeal circulation. Ann Thorac Surg 80:611-617
19. Zeng S, Dun H, Ippagunta N et al (2009) Receptor for advanced glycation end product (RAGE)-dependent modulation of early growth response-1 in hepatic ischemia/reperfusion injury. J Hepatol 50:929-936
20. Taguchi A, Blood DC, del Toro G et al (2000) Blockade of RAGE - amphoterin signalling suppresses tumour growth and metastases. Nature 405:354-360
21. Scaffidi P, Misteli T, Bianchi ME (2002) Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418:191-195
22. Ueno M, Moriyama Y, Toda R et al (2001) Effect of a neutrophil elastase inhibitor (ONO-5046 Na) on ischemia/reperfusion injury using the left-sided heterotopic canine heart transplantation model. J Heart Lung Transpl 20:889-896
23. Watanabe T, Kubota S, Nagaya M et al (2005) The role of HMGB1 on the development of necrosis during hepatic ischemia and hepatic ischemia/reperfusion injury in mice. J Surg Res 124:59-66
24. Rao NV, Argyle B, Xu X et al (2010) Low anticoagulant heparin targets multiple sites of inflammation, suppresses heparininduced thrombocytopenia, and inhibits interaction of RAGE with its ligands. Am J Physiol Cell Physiol 299:C97-C110
25. Medzhitov R, Janeway CA Jr (2002) Decoding the patterns of self and nonself by the innate immune system. Science 296:298-300
26. Kulmatycki KM, Jamali F (2001) Therapeutic relevance of altered cytokine expression. Cytokine 14:1-10
27. Lotze MT, Tracey KJ (2005) High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 5:331-342
28. Nakano Y, Kondo T, Matsuo R et al (2009) Prevention of leukocyte activation by the neutrophil elastase inhibitor, Sivelestat, in the hepatic microcirculation after ischemia-reperfusion. J Surg Res 155:311-317
29. Kwon AH, Qiu Z (2007) Neutrophil elastase inhibitor prevents endotoxin-induced liver injury following experimental partial hepatectomy. Br J Surg 94:609-619
30. Okajima K, Harada N, Uchiba M et al (2004) Neutrophil elastase contributes to the development of ischemia-reperfusion-induced liver injury by decreasing endothelial production of prostacyclin in rats. Am J Physiol Gastrointest Liver Physiol 287:G1116-G1123
31. Shimoda M, Iwasaki Y, Okada T et al (2008) Protective effect of sivelestat in a porcine hepatectomy model prepared using an intermittent Pringle method. Eur J Pharmacol 587:248-252